Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DNL-343 by Denali Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
DNL-343 is under clinical development by Denali Therapeutics and currently in Phase III for Amyotrophic Lateral Sclerosis. According to GlobalData,...